167 related articles for article (PubMed ID: 14710230)
1. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.
Itoi T; Yamana K; Bilim V; Takahashi K; Tomita F
Br J Cancer; 2004 Jan; 90(1):200-5. PubMed ID: 14710230
[TBL] [Abstract][Full Text] [Related]
2. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.
Zhu Z; Xing S; Cheng P; Li G; Yang Y; Zeng F; Lu G
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):354-7. PubMed ID: 15587397
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.
Zhang X; Takenaka I
Urology; 2000 Sep; 56(3):510-5. PubMed ID: 10962335
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis of renal cell carcinoma and apoptotic related genes bcl-2 and bax].
Yang B; Gu F; Li H; Kong X; Yu L
Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):373-5. PubMed ID: 11825416
[TBL] [Abstract][Full Text] [Related]
5. Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.
Oudard S; Levalois C; Andrieu JM; Bougaran J; Validire P; Thiounn N; Poupon MF; Fourme E; Chevillard S
Anticancer Res; 2002; 22(1A):121-8. PubMed ID: 12017273
[TBL] [Abstract][Full Text] [Related]
6. Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
Lee CT; Genega EM; Hutchinson B; Fearn PA; Kattan MW; Russo P; Reuter VE
Urol Oncol; 2003; 21(3):179-84. PubMed ID: 12810203
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
8. [Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis].
Li L; Yan L; Liu Z; Wang Z; Wen T; Chen X; Huang G
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):614-6, 120. PubMed ID: 11825479
[TBL] [Abstract][Full Text] [Related]
9. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.
Shin Lee J; Seok Kim H; Bok Kim Y; Cheol Lee M; Soo Park C
J Surg Oncol; 2003 Nov; 84(3):166-72. PubMed ID: 14598361
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas.
Gobé G; Rubin M; Williams G; Sawczuk I; Buttyan R
Cancer Invest; 2002; 20(3):324-32. PubMed ID: 12025227
[TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
Sejima T; Miyagawa I
Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
13. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
Tomita Y; Bilim V; Kawasaki T; Takahashi K; Okan I; Magnusson KP; Wiman KG
Int J Cancer; 1996 May; 66(3):322-5. PubMed ID: 8621251
[TBL] [Abstract][Full Text] [Related]
15. Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas.
Pepe S; Ruggiero A; D'Acquisto M; De Laurentiis M; De Placido S; Sandomenico C; Staibano S; De Rosa G; Lucariello A; D'Armiento M; Bianco AR
Cancer; 2000 Sep; 89(5):1065-75. PubMed ID: 10964337
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.
Kajiwara M; Toyoshima S; Yao T; Tanaka M; Tsuneyoshi M
J Surg Oncol; 1999 Apr; 70(4):209-16. PubMed ID: 10219015
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma.
Oda T; Takahashi A; Miyao N; Yanase M; Masumori N; Itoh N; Sato MA; Kon S; Tsukamoto T
Int J Urol; 2003 Jan; 10(1):13-8. PubMed ID: 12534920
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in transitional cell carcinoma of the renal pelvis and ureter: association with proliferative activity, bcl-2 expression and prognosis.
Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
J Urol; 1997 Sep; 158(3 Pt 1):750-3. PubMed ID: 9258073
[TBL] [Abstract][Full Text] [Related]
19. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
